reports
Sunrun and BGE Operate Nation’s First Residential Vehicle-To-Grid Dist...
Sunrun and BGE Operate Nation’s First Residential Vehicle-To-Grid Distributed Power Plant Using Ford F-150 Lightning Trucks Partnership with Sunrun, BGE, and Ford advances to vehicle-to-grid dispatch, showing how electric vehicles can help power America as electricity peak demand sets new records SAN FRANCISCO, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Sunrun (Nasdaq: RUN), America’s largest provider of home battery storage, solar, and home-to-grid power plants, has activated the nation’s first residential vehicle-to-grid distributed power plant in partnership with Maryland’s largest utility, ...
Lexicon Pharmaceuticals Announces Update on Submission of Additional D...
Lexicon Pharmaceuticals Announces Update on Submission of Additional Data to U.S. FDA Supporting the Benefit-Risk Profile of Zynquista® in Type 1 Diabetes Data obtained from ongoing third-party funded, investigator-sponsored trials have been submitted in effort to address the December 2024 complete response letter Company seeks alignment on reasonable path forward for Zynquista NDA resubmission FDA feedback from Type D meeting now expected during the fourth quarter THE WOODLANDS, Texas, Sept. 22, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: LXRX) today announced an update to the previous s...
Upwork Announces 2025 Investor Day
Upwork Announces 2025 Investor Day PALO ALTO, Calif., Sept. 17, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: UPWK), the world’s human and AI-powered work marketplace, today announced that it will host an Investor Day on Tuesday, November 18, 2025, beginning at 9:00 a.m. ET, in New York City. The event will feature presentations and a Q&A session led by members of the Company’s management team, including President and CEO Hayden Brown and CFO Erica Gessert. Presentations will be delivered in person and via live webcast accessible through Upwork’s Investor Relations website at . A replay of the webc...
Pilavapadin Provides Meaningful Pain Reduction in Adults with Diabetic...
Pilavapadin Provides Meaningful Pain Reduction in Adults with Diabetic Peripheral Neuropathic Pain (DPNP) in Data Presented at the European Association for the Study of Diabetes (EASD) and NEUROdiab Annual Meetings Pilavapadin 10 mg resulted in a two-point reduction from baseline in average daily pain scores (ADPS) by week 11 and was well tolerated in PROGRESS Phase 2b study THE WOODLANDS, Texas, Sept. 17, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: LXRX) today announced the presentation of clinical data from the company’s Phase 2b PROGRESS study for its investigational, AAK1-inhibitor, pilavapa...
Sunrun Prices $510 million Securitization, Surpassing $1.5 billion of ...
Sunrun Prices $510 million Securitization, Surpassing $1.5 billion of Non-Recourse Debt Capital Raised in the Third Quarter SAN FRANCISCO, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Sunrun (Nasdaq: RUN), America’s largest provider of residential battery storage, solar, and home-to-grid power plants, today announced it has priced a securitization of leases and power purchase agreements. The securitization is Sunrun’s fifteenth securitization since 2015 and fifth issuance in 2025. “Sunrun continues to show deep capital markets access, leveraging its strong relationships with both public and privat...
Frequency Electronics, Inc. Announces First Quarter Fiscal Year 2026 F...
Frequency Electronics, Inc. Announces First Quarter Fiscal Year 2026 Financial Results • Announces $20 million share repurchase authorization MITCHEL FIELD, N.Y., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Frequency Electronics, Inc. (“FEI” or the “Company”) (NASDAQ-FEIM) is pleased to announce its financial results for the first quarter of fiscal year 2026. Revenue for the first quarter ended July 31, 2025, was approximately $13.8 million, a decrease from the $15.1 million reported for the same period of fiscal year 2025. Operating income for the first quarter of fiscal...
Lexicon Pharmaceuticals to Present Additional Clinical Data on Pilavap...
Lexicon Pharmaceuticals to Present Additional Clinical Data on Pilavapadin at Three Upcoming Medical Meetings Presentations collectively highlight pilavapadin’s potential to improve pain management care for patients with diabetic peripheral neuropathic pain (DPNP) Breadth of the data across Phase 2 program to be discussed at Arrowhead’s 19th Annual Pain Summit THE WOODLANDS, Texas, Sept. 11, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: LXRX) today announced the presentation of clinical data for its investigational, AAK1-inhibitor, pilavapadin, for the treatment of diabetic peripheral neuropathic ...
Frequency Electronics Announces First Quarter Fiscal 2026 Financial Re...
Frequency Electronics Announces First Quarter Fiscal 2026 Financial Results Conference Call: Thursday, September 11, 2025, at 4:30 PM ET MITCHEL FIELD, N.Y., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Frequency Electronics, Inc. (NASDAQ: FEIM), will hold a conference call to discuss results for the first quarter of its fiscal year 2026, ended April 30, 2026, on Thursday, September 11, 2025, at 4:30 PM Eastern Time. This call is being webcast by Issuer Direct Corporation and can be accessed in the Investor Relations section of Frequency’s web site at . Investors and analysts may also access the c...
Lexicon Pharmaceuticals Announces Submission of Additional Data to U.S...
Lexicon Pharmaceuticals Announces Submission of Additional Data to U.S. FDA Supporting the Benefit-Risk Profile of Zynquista® in Type 1 Diabetes Data obtained from ongoing third-party funded, investigator-sponsored trials have been submitted in effort to address the December 2024 complete response letter Company seeks alignment on reasonable path forward for Zynquista NDA resubmission FDA feedback from Type D meeting expected by end of September THE WOODLANDS, Texas, Sept. 08, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: LXRX) today announced that the Company has submitted additional clini...
Lexicon Pharmaceuticals to Present New Preclinical Data on Pilavapadin...
Lexicon Pharmaceuticals to Present New Preclinical Data on Pilavapadin in Chemotherapy-Induced Pain and Multiple Sclerosis Pain at NeuPSIG 2025 THE WOODLANDS, Texas, Sept. 04, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: LXRX) today announced that the Company will present new data demonstrating the reduction of neuropathic pain by pilavapadin in preclinical models of chemotherapy-induced peripheral neuropathy (CIPN) and multiple sclerosis (MS) at the 9th International Congress on Neuropathic Pain - (NeuPSIG) 2025. The findings highlight the relevance of inhibiting pilavapadin’s novel target, AAK1, ...
Upwork Announces an Additional $100 Million Share Repurchase Program
Upwork Announces an Additional $100 Million Share Repurchase Program Third $100M share repurchase authorization announced since November 2023 PALO ALTO, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: UPWK), the world’s human and AI-powered work marketplace, today announced that its board of directors approved an additional $100 million share repurchase program. “Upwork’s financial results continue to exceed expectations, giving us another opportunity to utilize our balance sheet to increase shareholder value,” said Hayden Brown, president and CEO, Upwork. “Our track record of ope...
Lexicon Pharmaceuticals Announces Presentation of Diabetic Peripheral ...
Lexicon Pharmaceuticals Announces Presentation of Diabetic Peripheral Neuropathic Pain Patient Insights at PAINWeek 2025 THE WOODLANDS, Texas, Sept. 03, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: LXRX) today announced data from a study of patients describing the physical and psychological impact of diabetic peripheral neuropathic pain (DPNP), despite treatment with available over-the-counter and prescription pain relievers will be presented at PAINWeek 2025. The conference is being held September 2-4, 2025, at The Cosmopolitan in Las Vegas, Nevada. Presentation details: Poster #53: ...
Upwork Monthly Hiring Report: High-Value Work Grew 31% Among Large Bus...
Upwork Monthly Hiring Report: High-Value Work Grew 31% Among Large Businesses as AI Amplifies Demand for Human Skills Inaugural monthly analysis of the freelance economy provides an early signal of U.S. labor market shifts, revealing how businesses are engaging flexible talent August analysis shows demand for human-centric skills like fact-checking and video editing is on the rise PALO ALTO, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: UPWK), the world’s human and AI-powered work marketplace, today announced a new monthly analysis of hiring trends in the freelance economy, r...
Sotagliflozin Provides Consistent Relative Risk Reduction in Heart Fai...
Sotagliflozin Provides Consistent Relative Risk Reduction in Heart Failure and Major Cardiovascular Events Across All Age Ranges, Including Greater Than 75, in Data Presented at the European Society of Cardiology (ESC) 2025 Congress Oral presentation highlighted improvements in heart failure endpoints and major adverse cardiovascular events (MACE) among older adults irrespective of age THE WOODLANDS, Texas, Sept. 02, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: LXRX) announced that a post-hoc analysis (“Efficacy of Sotagliflozin Among Older Adults: A Pooled Analysis of SCORED and SOLOIST-WHF”) of...
Upwork to Present at Goldman Sachs Communacopia + Technology Conferenc...
Upwork to Present at Goldman Sachs Communacopia + Technology Conference PALO ALTO, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: UPWK), the world’s human and AI-powered work marketplace, today announced that CFO Erica Gessert will participate in a fireside chat at the Goldman Sachs Communacopia + Technology Conference in San Francisco, CA on Thursday, September 11, 2025 at 10:50 a.m. PT/1:50 p.m. ET. A live webcast of the fireside chat will be available in the Events and Presentations section of Upwork’s Investor Relations website at . A webcast archive will be available following ...
Lexicon Pharmaceuticals to Participate at Two Upcoming Investor Confer...
Lexicon Pharmaceuticals to Participate at Two Upcoming Investor Conferences THE WOODLANDS, Texas, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will participate in a fireside chat at Citi's Biopharma Back to School Conference on Wednesday, September 3 at 1:45 p.m. ET and at the H.C. Wainwright 27th Annual Global Investment Conference on Monday, September 8 at 3:00 p.m. ET. The live events and replays of the presentations can be accessed via the Events page of the Company’s website at . About Lexicon Pharmaceuticals...
FEI-Zyfer Announces Contract Award for $3.14 Million
FEI-Zyfer Announces Contract Award for $3.14 Million GARDEN GROVE, Calif., Aug. 25, 2025 (GLOBE NEWSWIRE) -- FEI-Zyfer, Inc., a wholly-owned subsidiary of Frequency Electronics, Inc. (“FEI” or the “Company”) (NASDAQ-FEIM), a leading provider of precision timing and frequency control products, is pleased to announce the receipt of a contract from the Defense Logistics Agency - Aviation Division at Redstone Arsenal, AL for additional systems in support of the Patriot Missile system. The base year (Year 1) contract value is $3.14 million dollars, with a period of performance through October ...
Upwork Inc. Introduces Lifted, a Subsidiary Serving Enterprises with F...
Upwork Inc. Introduces Lifted, a Subsidiary Serving Enterprises with Full Suite of Contingent Workforce Solutions Lifted, an Upwork company, pioneers offering to help enterprises source, contract, manage, and pay global contingent talent compliantly and at scale PALO ALTO, Calif., Aug. 19, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: UPWK), the world’s human and AI-powered work marketplace, today announced the launch of , a wholly owned subsidiary purpose-built to serve enterprise clients with a unified solution that combines talent sourcing, contracting, and workforce management across every typ...
- Dave Nicoski
- Ross LaDuke
Vital Signs: Actionable charts
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
UNH UNITEDHEALTH GROUP INCORPORATED
SEDG SOLAREDGE TECHNOLOGIES INC.
RUN SUNRUN INC.
ROFIN SINAR TECH
RRGB RED ROBIN GOURMET BURGERS INC.
PBYI PUMA BIOTECHNOLOGY INC.
KE KIMBALL ELECTRONICS
GAIA GAIA INC CL A
UEC UNIMIT ENGINEERING
FI FRANK'S INTERNATIONAL NV
FSLR FIRST SOLAR INC.
DK DELEK US HOLDINGS INC
NEON NEONODE INC.
LYFT LYFT
ZETA ZETA GLOBAL HLDGS CORP
ARHS ARHAUS INC
EVLV EVOLV TECHNOLOGIES HLDGS INC
ESEA EUROSEAS LTD
VERB VERB TECHNOLOGY COMPANY INC.
MPLN MULTIPLAN CORPORATION
BKTI BK TECHNOLOGIES CORP
RIGL RIGEL PHARMACEUTICALS INC.
CSIOX CATALYST PERINI STRATEGIC INCOM ORD
SCLX SCILEX HOLDING COMPANY
Upwork Appoints Anthony Kappus as Chief Operating Officer, Elevates Te...
Upwork Appoints Anthony Kappus as Chief Operating Officer, Elevates Technology and Legal Leaders for Next Chapter of Growth Redfin veteran joins as company’s first COO, Andrew Rabinovich elevated to chief technology officer, and Jacob McQuown becomes chief legal officer, bolstering executive leadership team PALO ALTO, Calif., Aug. 12, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: UPWK), the world’s human and AI-powered work marketplace, today announced that it has appointed Anthony Kappus as the company’s first-ever chief operating officer (COO). Additionally, Andrew Rabinovich has taken on expand...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.